Literature DB >> 17160633

Serum chromogranin A concentration and intradialytic hypotension in chronic haemodialysis patients.

Ilona Kurnatowska1, Michał Nowicki.   

Abstract

AIM: The aim of this study was to investigate the influence of haemodialysis on plasma chromogranin A (CgA) concentration and to assess the relationship between CgA, blood pressure, occurrence of intradialytic hypotension episodes and residual renal function, respectively.
METHODS: The study included 38 chronic haemodialysis patients (24 M, 14 F; mean age 56.2+/-13.6 years). Plasma CgA and blood pressure were measured before and after a mid-week dialysis. Control group included 10 age- and sex-matched healthy subjects.
RESULTS: Plasma CgA levels were on average 50-fold higher in HD patients than in the controls (699+/-138 vs. 14+/-6 U/L). In HD patients plasma CgA corrected for ultrafiltration rates significantly increased (to 836+/-214 U/L, P<0.001) at the end of dialysis procedure. In patients with (n=8) and without frequent symptomatic intradialytic hypotension episodes predialysis values of CgA were similar (701+/-169 vs. 698+/-132 U/L) but post-dialysis were significantly lower in the former group (746+/-312 vs. 860+/-177 U/L; P=0.03) despite a similar rate of ultrafiltration (2675+/-1009 and 2583+/-1311 ml, respectively). Accordingly, in patients with intradialytic hypotension an increase of plasma CgA during dialysis was also much lower than in patients without hypotension (45+/-81 vs. 163+/-144 U/L; P=0.001).
CONCLUSIONS: CgA undergoes marked accumulation in renal failure. The increase of plasma CgA during dialysis is impaired in subjects with intradialytic hypotension episodes, which confirms the role of autonomic dysfunction in the pathogenesis of this complication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160633     DOI: 10.1007/s11255-005-0078-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  19 in total

Review 1.  The chromogranin-secretogranin family.

Authors:  Laurent Taupenot; Kimberly L Harper; Daniel T O'Connor
Journal:  N Engl J Med       Date:  2003-03-20       Impact factor: 91.245

2.  Dialysis hypotension: a hemodynamic analysis.

Authors:  J T Daugirdas
Journal:  Kidney Int       Date:  1991-02       Impact factor: 10.612

3.  Arterial hypotension in chronic hemodialyzed patients.

Authors:  A E Daul; X L Wang; M C Michel; O E Brodde
Journal:  Kidney Int       Date:  1987-11       Impact factor: 10.612

4.  Is physiologic sympathoadrenal catecholamine release exocytotic in humans?

Authors:  M A Takiyyuddin; J H Cervenka; P A Sullivan; M R Pandian; R J Parmer; J A Barbosa; D T O'Connor
Journal:  Circulation       Date:  1990-01       Impact factor: 29.690

5.  Sympathetic nervous system hyperactivity in maintenance hemodialysis patients.

Authors:  J L Izzo; M S Izzo; R H Sterns; R B Freeman
Journal:  Trans Am Soc Artif Intern Organs       Date:  1982

6.  Relationship between renal function and blood level of chromogranin A.

Authors:  G Tramonti; M Ferdeghini; C Annichiarico; M Norpoth; C Donadio; R Bianchi; C Bianchi
Journal:  Ren Fail       Date:  2001 May-Jul       Impact factor: 2.606

7.  Adrenergic regulation of blood pressure in chronic renal failure.

Authors:  J J Lilley; J Golden; R A Stone
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

8.  Rapid radioimmunoassay of circulating chromogranin A: in vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure.

Authors:  D T O'Connor; M R Pandlan; E Carlton; J H Cervenka; R J Hslao
Journal:  Clin Chem       Date:  1989-08       Impact factor: 8.327

9.  Norepinephrine clearance, chromogranin A and dopamine beta hydroxylase in renal failure.

Authors:  M G Ziegler; B Kennedy; E Morrissey; D T O'Connor
Journal:  Kidney Int       Date:  1990-05       Impact factor: 10.612

10.  Effect of short-term treatment with low dosages of the proton-pump inhibitor omeprazole on serum chromogranin A levels in man.

Authors:  Massimo Giusti; Marilena Sidoti; Clara Augeri; Carla Rabitti; Francesco Minuto
Journal:  Eur J Endocrinol       Date:  2004-03       Impact factor: 6.664

View more
  4 in total

1.  Exaggerated blood pressure response to dynamic exercise despite chronic refractory hypotension: results of a human case study.

Authors:  Alice Rogan; Gordon McGregor; Charles Weston; Nithya Krishnan; Robert Higgins; Daniel Zehnder; Stephen M S Ting
Journal:  BMC Nephrol       Date:  2015-06-09       Impact factor: 2.388

2.  High-soluble CGA levels are associated with poor survival in bladder cancer.

Authors:  T Szarvas; B Jardin-Watelet; N Bourgoin; M J Hoffmann; P Nyirády; C Oláh; T Széll; A Csizmarik; B Hadaschik; H Reis
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

3.  A randomized trial of albumin infusion to prevent intradialytic hypotension in hospitalized hypoalbuminemic patients.

Authors:  Etienne Macedo; Bethany Karl; Euyhyun Lee; Ravindra L Mehta
Journal:  Crit Care       Date:  2021-01-06       Impact factor: 9.097

4.  Prevention of vascular calcification by the endogenous chromogranin A-derived mediator that inhibits osteogenic transdifferentiation.

Authors:  Setareh Orth-Alampour; Nathalie Gayrard; Silvia Salem; Àngel Argilés; Joachim Jankowski; Shruti Bhargava; Vera Jankowski; Bernard Jover; Cécile Notarnicola; Heidi Noels; Emiel P C van der Vorst; Christoph Kuppe; Michael Wolf; Claudia Goettsch; Wendy Theelen; Heike Bruck; Danilo Fliser; Joseph Loscalzo; Zhuojun Wu; Nikolaus Marx; Walter Zidek
Journal:  Basic Res Cardiol       Date:  2021-10-13       Impact factor: 17.165

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.